Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good sign for sure. FIns right around the corner too
Excellent post!
Huge upside here. With just a little more awareness, this could really pop off
Big time potential here, it's only a matter of time
Don't be afraid to tap the ask a little ;)
VSHC
"SmallCapVoice.com, Inc. announced today that a new audio interview with Visual Healthcare Corp. (NASDAQ OTC:VSHC.PK) is now available. The interview can be heard at http://smallcapvoice.com/blog/5-2-11-audio-interview-with-visual-healthcare-corp-otcbb-vshc
http://ih.advfn.com/p.php?pid=nmona&article=47524986"
VSHC
Visual Healthcare Corp. (the Company) (NASDAQ OTC: VSHC) announces today that work has begun on a Chinese based adaptation of the information technology grid that its clients use in their clinical trial applications.
This project has been launched in response to requests from both Chinese academic centers as well as Clinical Research Organization experts responding to Chinese government resolve to create a major domestic drug industry.
http://ih.advfn.com/p.php?pid=nmona&article=47263498
VSHC
The Company expects to book a first tranche of $2.5 of this $5.5 million agreement by the end of the year. """"Supporting other industries with automation solutions and smart systems like ours will be significant source of revenues in the future,"""" says Mr. Dab.
http://ih.advfn.com/p.php?pid=nmona&article=47903423"""
VSHC
Visual Healthcare Corp. (the ""Company"") (NASDAQ OTC: VSHC) is pleased to be able to announce today that it expects revenues for the fourth quarter of fiscal 2011 to be between $1,050,000 and $1,150,000. The mid-range of the current guidance is a record high since inception and represents a substantial increase from previous quarters in 2011. Based on these figures the Company can provide further guidance regarding year end revenues for the entire year which is expected to be between $1,460,000 and $1,550,000.
http://ih.advfn.com/p.php?pid=nmona&article=48078267&symbol=VSHC
Overall, a very positive day in the right direction
Everyone on an extended lunch break?
Good to see others are starting to take a look at this stock. It's only a matter of time
Primed and ready for take off!
Volume is much higher than what we've seen recently, just need to keep this up
The chart does look quite good
We might not see these levels again, this is a great opportunity to get in at these levels
Looking to scoop up some tomorrow, .0018 would be a good entry point
Great entry point, I'll be picking up more shares tomorrow
The lid is about to pop on this one
End of day push!
Looks like we're getting primed and ready for lift off
Definitely excited about how we close this week and what next week brings!
Phenomenal news for VSHC:
Visual Healthcare ADE Platform Attracts Positive Market Response
May 24, 2011 08:26:00 (ET)
RENO, Nev., May 24, 2011 /PRNewswire via COMTEX/ -- Visual Healthcare Corp. (the "Company") (nasdaq otc:VSHC) announces that it is seeing robust demand for the new stand-alone version of its powerful adverse drug event prevention technology. The company has begun to roll out this new ADE focused version to medical facilities as a direct response to the Obama administration's billion-dollar patient-safety program aimed at reducing preventable drug errors.
The stand-alone version can be deployed in less than six weeks and become operational immediately. Resulting cost savings are passed on to hospitals which can then recoup their investment in less than a year. Adverse drug events cost an average $7,000 per case, representing an annual burden in the millions which can be substantially reduced by using smart technology to make drug prescriptions safer.
"This rapid ramping up in ADE business is a vindication of our patient strategy," says Chairman Gerard Dab. "Our strength has always been patient-centric medical knowledge and we have resisted selling low value services with no future like many others in our field. Our revenues are simple to track. It all stems from medical content management for clinicians."
Mr. Dab continues making his point about high value revenues, stating that current Q4 is shaping up to be the best quarter in the Company's 11-year history. "We are expected to reach the million dollar mark," he adds reiterating that he sees some 20 deals having a value of more than $15 million in the next 12 months. "Subsequently as budgets increase, growth of this product line will continue to be exponential," concludes Mr. Dab.
The White House ADE initiative comes after a study showing that one in three patients admitted to hospitals suffers a medical error or accident. President Obama is challenging hospitals to dramatically cut mistakes and readmissions due to preventable errors or negligence by 40 percent, and cut preventable hospital readmissions by 20 percent. The first tranche of $1 billion is being funneled to the industry under the Patient Protection and Affordable Care Act.
"Reducing the massive incidence of drug errors in hospital can only be achieved by automation and using smart systems like ours," says Mr. Dab. "We have waited long years to have the need for our technology recognized by Public Policy. This considerable program demonstrates the seriousness of the Obama commitment to patient safety in America."
Visual Healthcare platforms for Adverse Drug Event applications are used successfully by over one thousand clinicians and have been demonstrated to reduce both morbidity and cost associated with hospital errors by more than 30% and deadly errors by 50%.
With news on the way, who would be selling at these levels?